本文报告500例硅油手术的结果,手术适应证包括:增殖性玻璃体视网膜病变248例(接近50％),视网膜巨大裂孔50例,后极部裂孔50例,增殖性糖尿病性视网膜病变106例,穿孔性眼外伤39例,其它7例。手术结果:术后6个月内解剖复位成功率为77％。同期内病人视力≥0.02者73％,而在最后复查时只有66％。在跟踪6个月解剖复位成功的病人中有38％视力≥0.1,5％≥0.4。67例尽管视网膜完全复位,但视力仍低于0.02。手术并发症和处理: (1)白内障:这是不可避免的,主要发生于有晶体病的患者。术后第一年白内障不会影响视力,但以后为了保持视功能必须行白内障手术。在硅油手术开始时,应尽可能保留晶体,以保护眼前段的结构。若视网膜已平复,则可等晶体完全混浊后与硅油一起摘出。这种白内障手术最好在硅油手术后6～18个月进 This article reports the results of 500 cases of silicone surgery, surgical indications include: proliferative vitreoretinopathy in 248 cases (nearly 50%), 50 cases of giant retinal holes, 50 cases of posterior pole hippocampus, proliferative diabetic retinopathy in 106 cases, perforation Eye trauma in 39 cases, the other 7 cases. Results: The success rate of anatomic reduction within 6 months after operation was 77%. Patients with visual acuity ≥ 0.02 during the same period 73%, while only 66% of the final review. In the follow-up 6 months anatomical reduction successful patients, 38% of visual acuity ≥ 0.1, 5% ≥ 0.4.67 despite the complete reattachment of the retina, but still less than 0.02 visual acuity. Surgical complications and management: (1) Cataract: This is inevitable, mainly in patients with crystal disease. Cataracts will not affect vision in the first year after surgery, but cataract surgery must be performed later in order to maintain visual function. At the beginning of silicone surgery, the crystal should be retained as much as possible to protect the anterior segment of the structure. If the retina has been restored, the crystal can be completely turbid after removal together with the silicone oil. This cataract surgery is best done 6 to 18 months after silicone oil surgery